Cargando…
Androgen Receptor Highjacks ErbB-2 Nuclear Function to Induce Triple Negative Breast Cancer Growth
Triple negative breast cancer (TNBC) has poor prognosis and neither established biomarkers nor therapeutic targets. On the one hand the androgen receptor (AR), a steroid hormone receptor (SR) which is expressed in 10-53% of TNBC and proved to be critical for BC proliferation, has been proposed as a...
Autores principales: | Deamicis, Agustina Roldán, Oakley, Robert H, Helguera, Sergio Andonegui, Lenze, Mariela B, Madera, Santiago, Russo, Rosalia I Cordo, Chervo, María F, Schillaci, Roxana, Fresno, Cristóbal, Cidlowski, John A, Elizalde, Patricia V, Proietti, Cecilia J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089663/ http://dx.doi.org/10.1210/jendso/bvab048.1635 |
Ejemplares similares
-
ODP441 NErbB-2 and Androgen Receptor Regulate a Gene Signature Involved in Immune Response and Favorable Outcome in TNBC
por: Elizalde, Patricia, et al.
Publicado: (2022) -
ODP438 Canonical and Non-canonical Function of EZH2 in Progesterone Receptor Target Genes in Breast Cancer
por: Elizalde, Patricia, et al.
Publicado: (2022) -
OR12-02 When the Glucocorticoid Receptor Meets the Mineralocorticoid Receptor in the Nucleus of Human Cells
por: Petrillo, Maria G, et al.
Publicado: (2020) -
SAT-005 Gene Expression and Behavioral Alterations in Mice with Conditional Knockout of GR, MR, or Both GR and MR in the Hippocampus
por: Oakley, Robert, et al.
Publicado: (2019) -
One Hormone for Two Receptors: Exploring Glucocorticoid Actions Mediated by the Glucocorticoid and Mineralocorticoid Receptors
por: Petrillo, Maria G, et al.
Publicado: (2021)